Atlas of Hepatocellular Carcinoma Pathology 1st ed. 2022 Edición
اطلس سرطان آسیب شناسی کارسینوما

Atlas of Hepatocellular Carcinoma Pathology 1st ed. 2022 Edición

کتاب اطلس سرطان  آسیب شناسی کارسینوما

این اطلس به گونه ای طراحی شده است که یک مرجع کاربرپسند برای کارآموزان آسیب شناسی و آسیب شناسان عمومی در مدیریت و تفسیر نمونه های کارسینوم سلولی کبدی باشد. این بیش از 550 عکس ناخالص و میکروسکوپی با کیفیت بالا با تمرکز بر کارسینوم سلول‌های کبدی و تقلیدکننده‌های آن ارائه می‌کند و طیف کاملی از انواع مختلف بافت‌شناسی کارسینوم سلول‌های کبدی را نشان می‌دهد. متن مقدماتی در هر فصل، انجمن‌های بالینی برجسته، ویژگی‌های پاتولوژیک، و تغییرات مولکولی انواع مختلف کارسینوم سلول‌های کبدی را خلاصه می‌کند. تمایز بین کارسینوم هپاتوسلولار و تقلید کننده های آن از طریق مطالعات موردی مختلف نشان داده شده است.

This atlas is designed to be a user-friendly bench-side reference for pathology trainees and general pathologists in handling and interpreting specimens of hepatocellular carcinoma. It provides over 550 high-quality gross and microscopic photos focusing on hepatocellular carcinoma and its mimickers, and demonstrating a full range of various histological variants of hepatocellular carcinoma. Introductory text in each chapter summarises salient clinical associations, pathological features, and molecular alterations of different variants of hepatocellular carcinoma. Differentiation between hepatocellular carcinoma and its mimickers is illustrated through various case studies.
The authors are nationally and internationally recognized hepatopathologists in the Asian-Pacific regions (Hong Kong, Korea, the Philippines, and Singapore), in which the incidence of hepatocellular carcinoma is high.The authors are nationally and internationally recognized hepatopathologists in the Asian-Pacific regions (Hong Kong, Korea, the Philippines, and Singapore), in which the incidence of hepatocellular carcinoma is high.The authors are nationally and internationally recognized hepatopathologists in the Asian-Pacific regions (Hong Kong, Korea, the Philippines, and Singapore), in which the incidence of hepatocellular carcinoma is high.The authors are nationally and internationally recognized hepatopathologists in the Asian-Pacific regions (Hong Kong, Korea, the Philippines, and Singapore), in which the incidence of hepatocellular carcinoma is high.The authors are nationally and internationally recognized hepatopathologists in the Asian-Pacific regions (Hong Kong, Korea, the Philippines, and Singapore), in which the incidence of hepatocellular carcinoma is high.The authors are nationally and internationally recognized hepatopathologists in the Asian-Pacific regions (Hong Kong, Korea, the Philippines, and Singapore), in which the incidence of hepatocellular carcinoma is high.The authors are nationally and internationally recognized hepatopathologists in the Asian-Pacific regions (Hong Kong, Korea, the Philippines, and Singapore), in which the incidence of hepatocellular carcinoma is high.